Clinical trial
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients…
NCT00062439 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00062439 |
|---|---|
| Title | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors |
| Official title | A Phase II Trial of Induction Chemoradiotherapy With Cisplatin/Etoposide Followed by Surgical Resection, Followed by Docetaxel, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group American College of Surgeons North Central Cancer Treatment Group NCIC Clinical Trials Group Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, docetaxel, etoposide, conventional surgery, radiation therapy |
| Enrollment | 46 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 6, 2003 |
| Last update posted | Nov 25, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: